A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy (Q94587776)

From Wikidata

Jump to navigation Jump to search

scientific article published on 06 May 2020

Language	Label	Description	Also known as
English	A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy	scientific article published on 06 May 2020

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Margaret A Fischl

11

object named as

Margaret A Fischl

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

author name string

Suresh Pallikkuth

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Hector Bolivar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Mary A Fletcher

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Dunja Z Babic

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Lesley R De Armas

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Sachin Gupta

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

James M Termini

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Kristopher L Arheart

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Mario Stevenson

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Frank Y Tung

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Savita Pahwa

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Geoffrey W Stone

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

publication date

6 May 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Life expectancy living with HIV: recent estimates and future implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Innate immunity against HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Cutting Edge: Distinct waves of BCL6 expression during T follicular helper cell development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Highly multiplexed quantitation of gene expression on single cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Immune activation during acute HIV infection and the impact of early antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Residual inflammation and viral reservoirs: alliance against an HIV cure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Systemic effects of inflammation on health during chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Ageing and inflammation in patients with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

T-cell exhaustion in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

HIV-1 Reservoirs During Suppressive Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

T cell exhaustion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Impact of Chronic HIV/SIV Infection on T Follicular Helper Cell Subsets and Germinal Center Homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Inadequate T follicular cell help impairs B cell immunity during HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.04.015

7 January 2021

Identifiers

10.1016/J.VACCINE.2020.04.015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32387010%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q94587776&oldid=1946347274"